nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—Urticaria—Teniposide—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Valaciclovir—Herpes simplex—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Valaciclovir—Abdominal pain—Teniposide—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Valaciclovir—Body temperature increased—Teniposide—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Valaciclovir—Paraesthesia—Fludarabine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Valaciclovir—Hallucination—Carmustine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Valaciclovir—Dyspnoea—Fludarabine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Valaciclovir—Haematuria—Mitoxantrone—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Valaciclovir—Oedema peripheral—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Valaciclovir—Dyspepsia—Fludarabine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Valaciclovir—Dysarthria—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Valaciclovir—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Valaciclovir—Decreased appetite—Fludarabine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Valaciclovir—Fatigue—Fludarabine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Valaciclovir—Hallucination—Vincristine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Valaciclovir—Pain—Fludarabine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Valaciclovir—Constipation—Fludarabine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Valaciclovir—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Valaciclovir—Urethral disorder—Vincristine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Valaciclovir—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Valaciclovir—Hypersensitivity—Teniposide—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Valaciclovir—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Valaciclovir—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Valaciclovir—Anaemia—Bleomycin—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Valaciclovir—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Valaciclovir—Asthenia—Teniposide—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Valaciclovir—Pruritus—Teniposide—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Valaciclovir—Leukopenia—Bleomycin—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Valaciclovir—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Valaciclovir—Alopecia—Carmustine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Valaciclovir—Body temperature increased—Fludarabine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Valaciclovir—Cough—Bleomycin—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Valaciclovir—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Valaciclovir—Diarrhoea—Teniposide—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Valaciclovir—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Valaciclovir—Chest pain—Bleomycin—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Valaciclovir—Myalgia—Bleomycin—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Valaciclovir—Alopecia—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Valaciclovir—Coma—Methotrexate—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Valaciclovir—Back pain—Carmustine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Valaciclovir—Chills—Mitoxantrone—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Valaciclovir—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Valaciclovir—Alopecia—Mitoxantrone—lymphatic system cancer	0.002	0.002	CcSEcCtD
Valaciclovir—Confusional state—Bleomycin—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Valaciclovir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Valaciclovir—Tremor—Carmustine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Valaciclovir—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Valaciclovir—Oedema—Bleomycin—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Valaciclovir—Infection—Bleomycin—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Valaciclovir—Anaemia—Carmustine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Valaciclovir—Back pain—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Valaciclovir—Vomiting—Teniposide—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Valaciclovir—Agitation—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Valaciclovir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Valaciclovir—Asthenia—Fludarabine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Valaciclovir—Rash—Teniposide—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Valaciclovir—Dermatitis—Teniposide—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Valaciclovir—Headache—Teniposide—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Valaciclovir—Pruritus—Fludarabine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Valaciclovir—Back pain—Mitoxantrone—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Valaciclovir—Leukopenia—Carmustine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Valaciclovir—Anorexia—Bleomycin—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Valaciclovir—Anaemia—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Valaciclovir—Agitation—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Valaciclovir—Photosensitivity—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Valaciclovir—Diarrhoea—Fludarabine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Valaciclovir—Convulsion—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Valaciclovir—Hypertension—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Valaciclovir—Nausea—Teniposide—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Valaciclovir—Anaemia—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Valaciclovir—Leukopenia—Vincristine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Valaciclovir—Chest pain—Carmustine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Valaciclovir—Myalgia—Carmustine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Valaciclovir—Paraesthesia—Bleomycin—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Valaciclovir—Dyspnoea—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Valaciclovir—Renal failure acute—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Valaciclovir—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Valaciclovir—Convulsion—Vincristine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Valaciclovir—Hypertension—Vincristine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Valaciclovir—Confusional state—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Valaciclovir—Oedema—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Valaciclovir—Decreased appetite—Bleomycin—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Valaciclovir—Myalgia—Vincristine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Valaciclovir—Cough—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Valaciclovir—Infection—Carmustine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Valaciclovir—Vomiting—Fludarabine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Valaciclovir—Convulsion—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Valaciclovir—Rash—Fludarabine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Valaciclovir—Dermatitis—Fludarabine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Valaciclovir—Hypertension—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Valaciclovir—Pain—Bleomycin—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Valaciclovir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Valaciclovir—Headache—Fludarabine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Valaciclovir—Tachycardia—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Valaciclovir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Valaciclovir—Chest pain—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Valaciclovir—Myalgia—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Valaciclovir—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Valaciclovir—Oedema—Vincristine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Valaciclovir—Anorexia—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Valaciclovir—Infection—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Valaciclovir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Valaciclovir—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Valaciclovir—Confusional state—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Valaciclovir—Nervous system disorder—Vincristine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Valaciclovir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Valaciclovir—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Valaciclovir—Oedema—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Valaciclovir—Nausea—Fludarabine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Valaciclovir—Infection—Mitoxantrone—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valaciclovir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valaciclovir—Urticaria—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valaciclovir—Anorexia—Vincristine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valaciclovir—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Valaciclovir—Body temperature increased—Bleomycin—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Valaciclovir—Insomnia—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Valaciclovir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Valaciclovir—Paraesthesia—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Valaciclovir—Dyspnoea—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Valaciclovir—Somnolence—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Valaciclovir—Anorexia—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Valaciclovir—Ataxia—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Valaciclovir—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Valaciclovir—Decreased appetite—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Valaciclovir—Insomnia—Vincristine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Valaciclovir—Paraesthesia—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Valaciclovir—Pain—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Valaciclovir—Constipation—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Valaciclovir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Valaciclovir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Valaciclovir—Decreased appetite—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Valaciclovir—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Valaciclovir—Somnolence—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Valaciclovir—Feeling abnormal—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Valaciclovir—Fatigue—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Valaciclovir—Asthenia—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Valaciclovir—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Valaciclovir—Pain—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Valaciclovir—Constipation—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Valaciclovir—Pruritus—Bleomycin—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Valaciclovir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Valaciclovir—Fatigue—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Valaciclovir—Constipation—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Valaciclovir—Pain—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Valaciclovir—Abdominal pain—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Valaciclovir—Body temperature increased—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Valaciclovir—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Valaciclovir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Valaciclovir—Abdominal pain—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Valaciclovir—Body temperature increased—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Valaciclovir—Urticaria—Mitoxantrone—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Valaciclovir—Hypersensitivity—Carmustine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Valaciclovir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Valaciclovir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Valaciclovir—Vomiting—Bleomycin—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Valaciclovir—Depression—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Valaciclovir—Rash—Bleomycin—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Valaciclovir—Dermatitis—Bleomycin—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Valaciclovir—Asthenia—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Valaciclovir—Renal failure—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Valaciclovir—Stomatitis—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Valaciclovir—Hypersensitivity—Vincristine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Valaciclovir—Haematuria—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Valaciclovir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Valaciclovir—Asthenia—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Valaciclovir—Diarrhoea—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Valaciclovir—Nausea—Bleomycin—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Valaciclovir—Asthenia—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Valaciclovir—Dizziness—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Valaciclovir—Diarrhoea—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Valaciclovir—Hepatitis—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Valaciclovir—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Valaciclovir—Urethral disorder—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Valaciclovir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Valaciclovir—Vomiting—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Valaciclovir—Dizziness—Vincristine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Valaciclovir—Rash—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Valaciclovir—Dermatitis—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Valaciclovir—Headache—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Valaciclovir—Vomiting—Vincristine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Valaciclovir—Rash—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Valaciclovir—Dermatitis—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Valaciclovir—Headache—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Valaciclovir—Nausea—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Valaciclovir—Vomiting—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Valaciclovir—Rash—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Valaciclovir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Valaciclovir—Chills—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Valaciclovir—Headache—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Valaciclovir—Nausea—Vincristine—lymphatic system cancer	0.000979	0.000979	CcSEcCtD
Valaciclovir—Nausea—Mitoxantrone—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—lymphatic system cancer	0.000948	0.000948	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—lymphatic system cancer	0.000906	0.000906	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Valaciclovir—Cough—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—lymphatic system cancer	0.000849	0.000849	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—lymphatic system cancer	0.000834	0.000834	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—lymphatic system cancer	0.000834	0.000834	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—lymphatic system cancer	0.000834	0.000834	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000829	0.000829	CcSEcCtD
Valaciclovir—Confusional state—Methotrexate—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.0008	0.0008	CcSEcCtD
Valaciclovir—Infection—Methotrexate—lymphatic system cancer	0.000795	0.000795	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000784	0.000784	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000783	0.000783	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—lymphatic system cancer	0.000777	0.000777	CcSEcCtD
Valaciclovir—Anorexia—Methotrexate—lymphatic system cancer	0.000763	0.000763	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000729	0.000729	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—lymphatic system cancer	0.000718	0.000718	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—lymphatic system cancer	0.000713	0.000713	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—lymphatic system cancer	0.000704	0.000704	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000691	0.000691	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Valaciclovir—Pain—Methotrexate—lymphatic system cancer	0.000684	0.000684	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000659	0.000659	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000654	0.000654	CcSEcCtD
Valaciclovir—Urticaria—Methotrexate—lymphatic system cancer	0.000635	0.000635	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—lymphatic system cancer	0.000632	0.000632	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—lymphatic system cancer	0.000632	0.000632	CcSEcCtD
Valaciclovir—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000589	0.000589	CcSEcCtD
Valaciclovir—Asthenia—Methotrexate—lymphatic system cancer	0.000574	0.000574	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—lymphatic system cancer	0.000566	0.000566	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Valaciclovir—Dizziness—Methotrexate—lymphatic system cancer	0.000529	0.000529	CcSEcCtD
Valaciclovir—Vomiting—Methotrexate—lymphatic system cancer	0.000509	0.000509	CcSEcCtD
Valaciclovir—Rash—Methotrexate—lymphatic system cancer	0.000504	0.000504	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—lymphatic system cancer	0.000504	0.000504	CcSEcCtD
Valaciclovir—Headache—Methotrexate—lymphatic system cancer	0.000501	0.000501	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—lymphatic system cancer	0.000475	0.000475	CcSEcCtD
